Integral Diagnostics (ASX:IDX) Tariff Resilience Score: 0/10 (As of Jul. 02, 2026)


ASX:IDX Integral Diagnostics Ltd ASX:IDX
75 GF Score
Price A$2.01
GF Value A$2.78
Valuation Modestly Undervalued
! 9 Warning Signs
View Full Analysis

What is Integral Diagnostics Tariff Resilience Score?

Integral Diagnostics has the Tariff Resilience Score of 0, which implies that the company might have .

Integral Diagnostics has

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Integral Diagnostics might have .

Integral Diagnostics  (ASX:IDX) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Integral Diagnostics Tariff Resilience Score Related Terms

ASX:IDX
75GF Score
Integral Diagnostics Ltd ASX:IDX
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Integral Diagnostics (ASX:IDX) Overvalued in 2026?

Based on GuruFocus' analysis, Integral Diagnostics stock appears to be undervalued. The current stock price of A$2.01 is trading 27.7% below its estimated GF Value™ of A$2.78. GuruFocus considers Integral Diagnostics to be Modestly Undervalued.

Key valuation signals for ASX:IDX:

  • Tariff Resilience Score: 0
  • GF Value™: A$2.78 vs. price of A$2.01 (27.7% below fair value)
  • GF Score™: 75/100 with 9 warning signs

No single metric tells the full story. See the ASX:IDX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Integral Diagnostics Business Description

Address 288 Victoria Parade, Level 2, Melbourne, VIC, AUS, 3002
Integral Diagnostics is a major Australian diagnostic imaging provider. In Australia, imaging revenues are almost entirely earned via the public health Medicare system. Integral typically earns approximately 90% of group revenue from diagnostic imaging in Australia and the remainder from diagnostic imaging in Auckland, New Zealand. In Australia, Integral services regional areas in Queensland, Victoria, New South Wales, and Western Australia.
75GF Score

Get the complete analysis for ASX:IDX

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$2.01
Price
A$2.78
GF Value